美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

ORUKA THERAPEUTICS INC

25.51

+1.024.14%

盤後：26.000.4950+1.94%19:42 EDT

成交量：53.81萬

成交額：1,358.23萬

市值：12.34億

市盈率：-11.90

高：26.19

開：25.36

低：24.46

收：24.49

52周最高：31.13

52周最低：5.49

股本：4,838.42萬

流通股本：2,240.81萬

量比：0.91

換手率：2.40%

股息：- -

股息率：- -

每股收益(TTM):-2.1429

每股收益(LYR):-3.8737

淨資產收益率：--

總資產收益率：--

市淨率：3.62

市盈率(LYR):-6.58

資料載入中...

總覽公司新聞公告

Oruka Therapeutics, Inc.盤中異動急速上漲5.21%

Oruka Therapeutics股價飆升20%創八個月新高，實驗性銀屑病藥物早期研究獲積極結果

ORUKA THERAPEUTICS INC宣佈完成1.8億美元私募孖展

Oruka Therapeutics, Inc.盤中異動早盤股價大跌5.16%報14.70美元

Oruka Therapeutics, Inc.盤中異動快速上漲5.07%報14.29美元

Oruka Therapeutics Inc 預計每股虧損 49 美分 - 財報前瞻

開山股份：下屬公司與SUPRACO簽署SMGP少數股權收購協議

Oruka Therapeutics, Inc.盤中異動股價大跌5.14%報14.57美元

Oruka Therapeutics, Inc.盤中異動急速上漲5.00%報14.06美元

Oruka Therapeutics, Inc.盤中異動早盤股價大跌5.82%

Oruka Therapeutics, Inc.2025財年第一財季實現淨利潤-21.00百萬美元，同比減少944.78%

Oruka Therapeutics, Inc.盤中異動股價大漲6.03%

Oruka Therapeutics, Inc.盤中異動快速跳水5.81%

Oruka Therapeutics, Inc.盤中異動早盤股價大跌5.51%報10.12美元

Oruka Therapeutics, Inc.盤中異動股價大跌5.26%報9.90美元

Oruka Therapeutics Inc 預計每股虧損 52 美分 - 財報前瞻

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ORKA/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ORKA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ORKA\",,,,,undefined,":{"symbol":"ORKA","market":"US","secType":"STK","nameCN":"ORUKA THERAPEUTICS INC","latestPrice":25.505,"timestamp":1760385600000,"preClose":24.49,"halted":0,"volume":538080,"hourTrading":{"tag":"盘后","latestPrice":26,"preClose":25.505,"latestTime":"19:42 EDT","volume":2768,"amount":70692.875,"timestamp":1760398945698},"delay":0,"floatShares":22408091,"shares":48384150,"eps":-2.142931,"marketStatus":"未開盤","change":1.015,"latestTime":"10-13 16:00:00 EDT","open":25.36,"high":26.185,"low":24.46,"amount":13582316.51904,"amplitude":0.070437,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.142931,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1760428800000},"marketStatusCode":0,"adr":0,"listingDate":871012800000,"exchange":"NASDAQ","adjPreClose":24.49,"preHourTrading":{"tag":"盘前","latestPrice":26.9,"preClose":24.49,"latestTime":"09:25 EDT","volume":27,"amount":697.550022,"timestamp":1760361909057},"postHourTrading":{"tag":"盘后","latestPrice":26,"preClose":25.505,"latestTime":"19:42 EDT","volume":2768,"amount":70692.875,"timestamp":1760398945698},"volumeRatio":0.907718,"impliedVol":0.8763,"impliedVolPercentile":0.5912},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ORKA\",,,,,undefined,":{"symbol":"ORKA","floatShares":22408091,"roa":"--","roe":"--","lyrEps":-3.873702,"volumeRatio":0.907718,"shares":48384150,"dividePrice":0,"high":26.185,"amplitude":0.070437,"preClose":24.49,"low":24.46,"week52Low":5.485,"pbRate":"3.62","week52High":31.13,"institutionHeld":0.9835,"latestPrice":25.505,"eps":-2.142931,"divideRate":0,"volume":538080,"delay":0,"ttmEps":-2.142931,"open":25.36,"prevYearClose":19.39,"prevWeekClose":24.49,"prevMonthClose":19.23,"prevQuarterClose":19.23,"fiveDayClose":20.33,"twentyDayClose":15.26,"sixtyDayClose":14.54},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ORKA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-09-03","symbol":"ORKA","defaultRemindTime":1725370200000,"type":"split","dateTimestamp":1725336000000,"forFactor":12,"toFactor":1,"ratio":12},{"date":"2024-08-29","symbol":"ORKA","amount":1.613,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-08-26","defaultRemindTime":1724938200000,"name":"方舟生物医药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-08-28","payableDate":"2024-08-26","currency":"USD","dateTimestamp":1724904000000,"payDate":"2024-08-28"},{"market":"US","date":"2024-08-01","symbol":"ORKA","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1722484800000,"reportTimeType":"post","actualEps":-0.18},{"market":"US","date":"2024-04-25","symbol":"ORKA","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1714017600000,"reportTimeType":"post","actualEps":-0.14},{"market":"US","date":"2024-02-01","symbol":"ORKA","fiscalQuarterEnding":"2023/12","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1706763600000,"reportTimeType":"post","actualEps":-0.08}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ORKA\",market:\"US\",,,undefined,":[{"executeDate":"2024-08-29","recordDate":"2024-08-26","paymentDate":"2024-08-28","value":1.613,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ORKA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6,"buy":0.4,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6,"analysts":10,"updateTime":1755921600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ORKA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ORKA","date":"2025-10-10","current":-11.901923,"percent":0,"low":-11.49024,"twenty":-5.309118,"median":-4.714571,"eighty":-3.994896,"high":-2.779284,"avg":-4.746632,"sd":1.011255,"marketCap":1236215032},"quantilePoints":[{"date":"2025-03-14","current":-4.566552,"twenty":-4.600166,"median":-4.533759,"eighty":-4.155287,"marketCap":417087281},{"date":"2025-03-21","current":-4.898591,"twenty":-4.788731,"median":-4.634189,"eighty":-4.465422,"marketCap":447414094},{"date":"2025-03-28","current":-4.898591,"twenty":-4.90187,"median":-4.734621,"eighty":-4.543597,"marketCap":447414094},{"date":"2025-04-04","current":-3.656521,"twenty":-4.90187,"median":-4.68543,"eighty":-4.155287,"marketCap":333969349},{"date":"2025-04-11","current":-3.021139,"twenty":-4.898591,"median":-4.546056,"eighty":-3.567158,"marketCap":275936558},{"date":"2025-04-17","current":-3.529445,"twenty":-4.883833,"median":-4.205819,"eighty":-3.28595,"marketCap":322362791},{"date":"2025-04-25","current":-4.304201,"twenty":-4.810047,"median":-4.25501,"eighty":-3.440082,"marketCap":393125355},{"date":"2025-05-02","current":-4.136132,"twenty":-4.747739,"median":-4.214018,"eighty":-3.521247,"marketCap":377774745},{"date":"2025-05-09","current":-3.996758,"twenty":-4.714945,"median":-4.198946,"eighty":-3.605691,"marketCap":365044972},{"date":"2025-05-16","current":-3.364967,"twenty":-4.682151,"median":-4.136132,"eighty":-3.605691,"marketCap":354187224},{"date":"2025-05-23","current":-3.980336,"twenty":-4.607544,"median":-4.002451,"eighty":-3.625269,"marketCap":418959306},{"date":"2025-05-30","current":-4.215101,"twenty":-4.558354,"median":-4.038702,"eighty":-3.660839,"marketCap":443670043},{"date":"2025-06-06","current":-4.336041,"twenty":-4.541137,"median":-4.079934,"eighty":-3.705732,"marketCap":456399816},{"date":"2025-06-13","current":-4.57792,"twenty":-4.558354,"median":-4.136132,"eighty":-3.769048,"marketCap":481859363},{"date":"2025-06-20","current":-4.261343,"twenty":-4.543597,"median":-4.170639,"eighty":-3.777968,"marketCap":448537309},{"date":"2025-06-27","current":-4.136846,"twenty":-4.523383,"median":-4.154632,"eighty":-3.785238,"marketCap":435433131},{"date":"2025-07-03","current":-4.48188,"twenty":-4.48188,"median":-4.154632,"eighty":-3.808193,"marketCap":471750426},{"date":"2025-07-11","current":-5.004766,"twenty":-4.566552,"median":-4.184867,"eighty":-3.812292,"marketCap":526787975},{"date":"2025-07-18","current":-5.463625,"twenty":-4.701827,"median":-4.197316,"eighty":-3.861483,"marketCap":575086233},{"date":"2025-07-25","current":-5.061679,"twenty":-4.767415,"median":-4.21456,"eighty":-3.877182,"marketCap":532778457},{"date":"2025-08-01","current":-4.834028,"twenty":-4.898055,"median":-4.257786,"eighty":-3.894967,"marketCap":508816530},{"date":"2025-08-08","current":-4.862484,"twenty":-4.898591,"median":-4.281656,"eighty":-3.898524,"marketCap":511811771},{"date":"2025-08-15","current":-5.221398,"twenty":-4.905169,"median":-4.336041,"eighty":-3.910674,"marketCap":561761175},{"date":"2025-08-22","current":-5.148299,"twenty":-5.001209,"median":-4.36364,"eighty":-3.910674,"marketCap":553896518},{"date":"2025-08-29","current":-5.315383,"twenty":-5.050833,"median":-4.460538,"eighty":-3.918873,"marketCap":571872876},{"date":"2025-09-05","current":-5.210955,"twenty":-5.062675,"median":-4.474766,"eighty":-3.936742,"marketCap":560637652},{"date":"2025-09-12","current":-5.621705,"twenty":-5.07235,"median":-4.48188,"eighty":-3.943016,"marketCap":604829531},{"date":"2025-09-19","current":-5.771385,"twenty":-5.152476,"median":-4.546056,"eighty":-3.972962,"marketCap":620933352},{"date":"2025-09-26","current":-5.238803,"twenty":-5.191462,"median":-4.609934,"eighty":-3.980356,"marketCap":563633712},{"date":"2025-10-03","current":-6.676428,"twenty":-5.243928,"median":-4.669033,"eighty":-3.986032,"marketCap":718305289},{"date":"2025-10-10","current":-11.49024,"twenty":-5.309118,"median":-4.714571,"eighty":-3.994896,"marketCap":1236215032}],"updateTime":1760423676205},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ORKA\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2569530257","title":"Oruka Therapeutics, Inc.盤中異動 急速上漲5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2569530257","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569530257?lang=zh_tw&edition=fundamental","pubTime":"2025-09-22 23:21","pubTimestamp":1758554487,"startTime":"0","endTime":"0","summary":"北京时间2025年09月22日23时21分，Oruka Therapeutics, Inc.股票出现波动，股价大幅上涨5.21%。Oruka Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.76%。其相关个股中，Mbx Biosciences, Inc.、Qualigen Therapeutics, Inc.、Metsera, Inc.涨幅较大，Qualigen Therapeutics, Inc.、Onconetix, Inc.、Mbx Biosciences, Inc.较为活跃，换手率分别为2777.25%、150.36%、59.73%，振幅较大的相关个股有Qualigen Therapeutics, Inc.、Mbx Biosciences, Inc.、Kodiak Sciences Inc，振幅分别为114.44%、64.50%、42.92%。Oruka Therapeutics, Inc.公司简介：Oruka Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发用于银屑病和其他炎症和免疫学（I&I）适应症的新型单克隆抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922232127953e1b7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922232127953e1b7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORKA","BK4139","LENZ","BK4007","BK4539"],"gpt_icon":0},{"id":"1122709697","title":"Oruka Therapeutics股價飆升20%創八個月新高，實驗性銀屑病藥物早期研究獲積極結果","url":"https://stock-news.laohu8.com/highlight/detail?id=1122709697","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122709697?lang=zh_tw&edition=fundamental","pubTime":"2025-09-17 21:37","pubTimestamp":1758116240,"startTime":"0","endTime":"0","summary":"Oruka Therapeutics股价大涨20%，达到八个月以来的最高水平。该公司宣布其实验性银屑病治疗药物的早期阶段研究获得积极结果，推动股价强劲上扬。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ORKA"],"gpt_icon":0},{"id":"1113250817","title":"ORUKA THERAPEUTICS INC宣佈完成1.8億美元私募孖展","url":"https://stock-news.laohu8.com/highlight/detail?id=1113250817","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113250817?lang=zh_tw&edition=fundamental","pubTime":"2025-09-17 13:03","pubTimestamp":1758085412,"startTime":"0","endTime":"0","summary":"加利福尼亚州门洛帕克，2025年9月17日——专注于开发创新生物制剂以治疗慢性皮肤疾病的生物技术公司ORUKA THERAPEUTICS INC今日宣布，公司已签署证券购买协议，进行私募股权投资融资，预计将为公司带来约1.8亿美元的总收益，扣除承销费用和发行费用前。此次PIPE融资由Viking Global Investors牵头，新老投资者均有参与，包括Affinity Healthcare Fund、Blackstone Multi-Asset Investing、Commodore Capital、Cormorant Asset Management、Deep Track Capital、Fairmount、Great Point Partners LLC、Palo Alto Investors LP、Perceptive Advisors、Surveyor Capital、Venrock Healthcare Capital Partners、Woodline Partners LP以及一支领先的生命科学投资基金等。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LENZ","BK4139","BK4539","ORKA"],"gpt_icon":0},{"id":"2557030366","title":"Oruka Therapeutics, Inc.盤中異動 早盤股價大跌5.16%報14.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557030366","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557030366?lang=zh_tw&edition=fundamental","pubTime":"2025-08-06 22:08","pubTimestamp":1754489306,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日22时08分，Oruka Therapeutics, Inc.股票出现波动，股价快速跳水5.16%。Oruka Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。Oruka Therapeutics, Inc.公司简介：Oruka Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发用于银屑病和其他炎症和免疫学（I&I）适应症的新型单克隆抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806220827a6d6c3d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806220827a6d6c3d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4539","BK4139","ORKA"],"gpt_icon":0},{"id":"2557335702","title":"Oruka Therapeutics, Inc.盤中異動 快速上漲5.07%報14.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557335702","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557335702?lang=zh_tw&edition=fundamental","pubTime":"2025-08-05 02:27","pubTimestamp":1754332032,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日02时27分，Oruka Therapeutics, Inc.股票出现异动，股价急速拉升5.07%。Oruka Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.41%。Oruka Therapeutics, Inc.公司简介：Oruka Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发用于银屑病和其他炎症和免疫学（I&I）适应症的新型单克隆抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080502271294cf6644&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080502271294cf6644&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORKA","BK4539","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2554776005","title":"Oruka Therapeutics Inc  預計每股虧損 49 美分 - 財報前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2554776005","media":"路透中文","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554776005?lang=zh_tw&edition=fundamental","pubTime":"2025-07-28 19:43","pubTimestamp":1753702988,"startTime":"0","endTime":"0","summary":"Oruka Therapeutics Inc  预计每股亏损 49 美分 - 财报前瞻Oruka Therapeutics Inc ORKA.OQ ORKA.O 预计将于7月30日公布截至2025年6月30日的业绩(估计)。LSEG分析师对Oruka Therapeutics Inc的平均预期是每股亏损49美分。华尔街对 Oruka Therapeutics Inc 的 12 个月目标价中位数为 42.50 美元，比上次收盘价 14.25 美元高出约 66.5%。7月28日 - 上一季度业绩。除非另有说明，所有数字均以美元为单位。如有任何其他问题或反馈，请联系 RefinitivNewsSupport@thomsonreuters.com。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250728:nL4T3TP0U5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORKA"],"gpt_icon":0},{"id":"2554721359","title":"開山股份：下屬公司與SUPRACO簽署SMGP少數股權收購協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2554721359","media":"格隆汇","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554721359?lang=zh_tw&edition=fundamental","pubTime":"2025-07-28 16:16","pubTimestamp":1753690613,"startTime":"0","endTime":"0","summary":"SMGP在印度尼西亚持有规模为240兆瓦地热发电项目的准证以及购电协议。日前，OTP以及公司设立在新加坡的全资下属公司KS Orka Renewables Pte. Ltd.分别与Supraco签署《有条件股权收购协议》，合计以300万美元现金收购Supraco持有的SMGP全部股份。在满足股权收购协议交割先决条件后，各方进行股权交割。交易完成后，OTP将持有SMGP98.57%的股份，KSO将持有SMGP1.43%的股份，即公司持有SMGP100%股份。Supraco 高管不再担任 SMGP 董事、监事等职务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507281617339722cdb2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507281617339722cdb2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ORKA"],"gpt_icon":0},{"id":"2552491550","title":"Oruka Therapeutics, Inc.盤中異動 股價大跌5.14%報14.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552491550","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552491550?lang=zh_tw&edition=fundamental","pubTime":"2025-07-19 00:23","pubTimestamp":1752855785,"startTime":"0","endTime":"0","summary":"北京时间2025年07月19日00时23分，Oruka Therapeutics, Inc.股票出现异动，股价大幅下跌5.14%。Oruka Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.22%。Oruka Therapeutics, Inc.公司简介：Oruka Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发用于银屑病和其他炎症和免疫学（I&I）适应症的新型单克隆抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071900230597ab5738&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071900230597ab5738&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORKA","BK4007","BK4539","BK4139","LENZ"],"gpt_icon":0},{"id":"2550486651","title":"Oruka Therapeutics, Inc.盤中異動 急速上漲5.00%報14.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550486651","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550486651?lang=zh_tw&edition=fundamental","pubTime":"2025-07-09 23:34","pubTimestamp":1752075284,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日23时34分，Oruka Therapeutics, Inc.股票出现波动，股价急速上涨5.00%。Oruka Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.13%。Oruka Therapeutics, Inc.公司简介：Oruka Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发用于银屑病和其他炎症和免疫学（I&I）适应症的新型单克隆抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709233444979fd10b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709233444979fd10b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","BK4139","ORKA","LENZ"],"gpt_icon":0},{"id":"2545417050","title":"Oruka Therapeutics, Inc.盤中異動 早盤股價大跌5.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545417050","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545417050?lang=zh_tw&edition=fundamental","pubTime":"2025-06-23 21:38","pubTimestamp":1750685926,"startTime":"0","endTime":"0","summary":"北京时间2025年06月23日21时38分，Oruka Therapeutics, Inc.股票出现波动，股价急速下挫5.82%。Oruka Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。Oruka Therapeutics, Inc.公司简介：Oruka Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发用于银屑病和其他炎症和免疫学（I&I）适应症的新型单克隆抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623213846a718f4e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623213846a718f4e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","BK4139","LENZ","ORKA"],"gpt_icon":0},{"id":"2537923272","title":"Oruka Therapeutics, Inc.2025財年第一財季實現淨利潤-21.00百萬美元，同比減少944.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537923272","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537923272?lang=zh_tw&edition=fundamental","pubTime":"2025-05-23 00:00","pubTimestamp":1747929645,"startTime":"0","endTime":"0","summary":"5月23日，Oruka Therapeutics, Inc.公布财报，公告显示公司2025财年第一财季净利润为-21.00百万美元，同比减少944.78%；其中营业收入为0.00美元，每股基本收益为-0.50美元。机构评级：截至2025年5月23日，当前有8家机构对Oruka Therapeutics, Inc.目标价做出预测，其中目标均价为39.50美元，其中最低目标价为15.00美元，最高目标价为47.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523000252a4887767&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523000252a4887767&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ORKA"],"gpt_icon":0},{"id":"2535351311","title":"Oruka Therapeutics, Inc.盤中異動 股價大漲6.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535351311","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535351311?lang=zh_tw&edition=fundamental","pubTime":"2025-05-16 21:58","pubTimestamp":1747403910,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日21时58分，Oruka Therapeutics, Inc.股票出现波动，股价急速上涨6.03%。Oruka Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。其相关个股中，Affimed N.V.、Inozyme Pharma, Inc.、Vor Biopharma Inc.涨幅较大，Affimed N.V.、Polyrizon Ltd.、Nucana Plc较为活跃，换手率分别为2520.58%、1760.50%、937.57%，振幅较大的相关个股有Affimed N.V.、Vor Biopharma Inc.、阿卡迪亚，振幅分别为466.98%、62.73%、37.95%。Oruka Therapeutics, Inc.公司简介：Oruka Therapeutics Inc 正在开发新型生物制剂，旨在为慢性皮肤病的治疗制定新标准。它为患有斑块状牛皮癣等慢性皮肤病的患者提供服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516215830a480feb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516215830a480feb6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ORKA","BK4539","BK4139","LENZ"],"gpt_icon":0},{"id":"2533650077","title":"Oruka Therapeutics, Inc.盤中異動 快速跳水5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533650077","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533650077?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 01:37","pubTimestamp":1746553041,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日01时37分，Oruka Therapeutics, Inc.股票出现异动，股价大幅跳水5.81%。Oruka Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为5.68%。其相关个股中，Liminatus Pharma Inc C/Wts 30/04/2030 、Celularity Inc C/Wts 16/07/2026 、Sol-Gel Technologies Ltd.涨幅较大，Pasithea Therapeutics Corp.、Galmed Pharmaceuticals Ltd.、Nucana Plc较为活跃，换手率分别为8106.96%、1208.01%、525.63%，振幅较大的相关个股有Pasithea Therapeutics Corp.、Celularity Inc C/Wts 16/07/2026 、Protagenic Therapeutics, Inc.，振幅分别为162.68%、69.05%、47.02%。Oruka Therapeutics, Inc.公司简介：Oruka Therapeutics Inc 正在开发新型生物制剂，旨在为慢性皮肤病的治疗制定新标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507013721aa2c84e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507013721aa2c84e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","ORKA"],"gpt_icon":0},{"id":"2533858794","title":"Oruka Therapeutics, Inc.盤中異動 早盤股價大跌5.51%報10.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533858794","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533858794?lang=zh_tw&edition=fundamental","pubTime":"2025-05-05 21:43","pubTimestamp":1746452580,"startTime":"0","endTime":"0","summary":"北京时间2025年05月05日21时43分，Oruka Therapeutics, Inc.股票出现波动，股价大幅下跌5.51%。截至发稿，该股报10.12美元/股，成交量1.47万股，换手率0.04%，振幅2.15%。Oruka Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Oruka Therapeutics, Inc.公司简介：Oruka Therapeutics Inc 正在开发新型生物制剂，旨在为慢性皮肤病的治疗制定新标准。它为患有斑块状牛皮癣等慢性皮肤病的患者提供服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250505214301a6d3e361&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250505214301a6d3e361&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","ORKA"],"gpt_icon":0},{"id":"2531205911","title":"Oruka Therapeutics, Inc.盤中異動 股價大跌5.26%報9.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531205911","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531205911?lang=zh_tw&edition=fundamental","pubTime":"2025-04-30 22:13","pubTimestamp":1746022391,"startTime":"0","endTime":"0","summary":"北京时间2025年04月30日22时13分，Oruka Therapeutics, Inc.股票出现波动，股价快速下跌5.26%。Oruka Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。其相关个股中，Regulus Therapeutics Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Nutriband Inc C/Wts 涨幅较大，Purple Biotech Ltd、Regulus Therapeutics Inc.、Silo Pharma, Inc.较为活跃，换手率分别为138.55%、26.27%、12.83%，振幅较大的相关个股有Nutriband Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026、Osr Holdings Inc C/Wts 09/02/2028 ，振幅分别为29.23%、25.02%、24.50%。Oruka Therapeutics, Inc.公司简介：Oruka Therapeutics Inc 正在开发新型生物制剂，旨在为慢性皮肤病的治疗制定新标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430221312a46dcfbc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430221312a46dcfbc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORKA","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2529114872","title":"Oruka Therapeutics Inc  預計每股虧損 52 美分 - 財報前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2529114872","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529114872?lang=zh_tw&edition=fundamental","pubTime":"2025-04-21 19:17","pubTimestamp":1745234227,"startTime":"0","endTime":"0","summary":"Oruka Therapeutics Inc  预计每股亏损 52 美分 - 财报前瞻Oruka Therapeutics Inc ORKA.OQ ORKA.O 预计将于4月23日公布截至2025年3月31日的业绩(估计)。LSEG分析师对Oruka Therapeutics Inc的平均预期是每股亏损52美分。华尔街对 Oruka Therapeutics Inc 的 12 个月目标价中位数为 41.00 美元，高于其最新收盘价 9.22 美元。4月21日 - 上一季度业绩。除非另有说明，所有数字均以美元为单位。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250421:nL4T3QZ0OB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORKA"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":16,"code":"91000000","status":"200"}]}}